History
  • No items yet
midpage
Novartis Ag v. Focarino
740 F.3d 593
Fed. Cir.
2014
Read the full case

Background

  • Novartis challenged PTO patent term adjustment determinations under 35 U.S.C. § 154(b) (2011).
  • District court dismissed 15 of 18 claims as untimely; three claims survived on merits.
  • Novartis asserted two § 154(b)(1)(B) interpretations and sought Wyeth v. Kappos recalculation.
  • District court held PTO interpretation correct for timeliness but partly incorrect for § 154(b)(1)(B) interpretations.
  • Court affirmed timeliness ruling for 15 patents and remanded 3 for redetermination of adjustments; Fifth Amendment claim was not resolved on timeliness.
  • No costs; judgment: affirmed in part, reversed in part, remanded.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Timeliness under § 154(b)(4) for final determinations Novartis argues 180-day clock applies only to provisional determinations. PTO contends 180-day period covers final determinations as reviewed under § 154(b)(4). 180-day period applies to final determinations.
Continued examination and the three-year pendency Continued examination time should count against the three-year limit if initiated after three years. Time spent in continued examination, regardless of initiation, does not count toward the three-year pendency. PTO interpretation correct: continued examination does not deplete three-year pendency.
Allowance-to-issuance time and continued examination Time after allowance should be excluded only if continued examination resumes. Time after allowance, until issuance, is excluded if caused by continued examination. Time after allowance to issuance is not automatically excluded; no continued examination in these cases.
Wyeth recalculation and Takings arguments Novartis seeks Wyeth-based recalculation and claims taking under Fifth Amendment. Wyeth recalculation applies only where appropriate; no takings here due to self-help timing rule. Recalculation limited to appropriate cases; Fifth Amendment takings rejected on these facts.

Key Cases Cited

  • Wyeth v. Kappos, 591 F.3d 1364 (Fed. Cir. 2010) (addressed overlap of delay periods in § 154(b)(2) and Wyeth standard applied)
  • United States v. Locke, 471 U.S. 84 (Supreme Court, 1985) (takings not compensating for consequences of own neglect)
  • Hosl West Virginia Univ. Hosp., Inc. v. Casey, 499 U.S. 83 (Supreme Court, 1991) (statutory interpretation principles; avoid nonsense results)
  • Holland v. Florida, 560 U.S. 631 (Supreme Court, 2010) (equitable tolling standards; diligence and extraordinary circumstances)
  • Venture Coal Sales Co. v. United States, 370 F.3d 1102 (Fed. Cir. 2004) (equitable tolling not available where theory was known earlier)
  • Commc’ns Vending Corp. of Arizona Inc. v. FCC, 365 F.3d 1064 (D.C. Cir. 2004) (timely filing and statutory interpretation principles)
  • BlackLight Power, Inc. v. Rogan, 295 F.3d 1269 (Fed. Cir. 2002) (exceptional action to withdraw from issue; resumption of examination)
Read the full case

Case Details

Case Name: Novartis Ag v. Focarino
Court Name: Court of Appeals for the Federal Circuit
Date Published: Jan 15, 2014
Citation: 740 F.3d 593
Docket Number: 20-1724
Court Abbreviation: Fed. Cir.